Travatrelvir, an Inhibitor of SARS CoV 2 Main Protease now in Phase 1 Clinical Trials: in vitro Drug Resistance Compared to Nirmatrelvir
356V Travatrelvir, an Inhibitor of SARS-CoV-2 Main...
Source: marketscreener.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Resistance Compared. Real-time updates on events, politics, business and more.